

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to lipoprotein particle (GO:0055094) | 6.79507251 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.32718922 |
| 3 | positive regulation of cell size (GO:0045793) | 4.62627245 |
| 4 | negative regulation of neurotransmitter transport (GO:0051589) | 4.51482064 |
| 5 | nucleobase catabolic process (GO:0046113) | 4.45381153 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.93589970 |
| 7 | microtubule nucleation (GO:0007020) | 3.89962739 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.77944451 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.74611197 |
| 10 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.74385170 |
| 11 | axonal fasciculation (GO:0007413) | 3.72508776 |
| 12 | positive regulation of catecholamine secretion (GO:0033605) | 3.72503280 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 3.64550506 |
| 14 | nerve growth factor signaling pathway (GO:0038180) | 3.62779293 |
| 15 | regulation of plasminogen activation (GO:0010755) | 3.52421146 |
| 16 | glutamate secretion (GO:0014047) | 3.48628268 |
| 17 | cellular protein complex localization (GO:0034629) | 3.46510752 |
| 18 | protein localization to synapse (GO:0035418) | 3.42872109 |
| 19 | presynaptic membrane assembly (GO:0097105) | 3.40934654 |
| 20 | cell wall macromolecule metabolic process (GO:0044036) | 3.33394598 |
| 21 | presynaptic membrane organization (GO:0097090) | 3.32050563 |
| 22 | synaptic vesicle maturation (GO:0016188) | 3.31934941 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.25399077 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 3.25329486 |
| 25 | neuron recognition (GO:0008038) | 3.24530027 |
| 26 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.21898622 |
| 27 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.20175417 |
| 28 | postsynaptic membrane organization (GO:0001941) | 3.07328289 |
| 29 | behavioral defense response (GO:0002209) | 3.01850590 |
| 30 | behavioral fear response (GO:0001662) | 3.01850590 |
| 31 | skeletal muscle organ development (GO:0060538) | 3.00594597 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.00284104 |
| 33 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.99993364 |
| 34 | cartilage morphogenesis (GO:0060536) | 2.99376761 |
| 35 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.97143711 |
| 36 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.96437640 |
| 37 | synaptic vesicle exocytosis (GO:0016079) | 2.96412413 |
| 38 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.88810087 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 2.87099733 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.81653326 |
| 41 | cell wall macromolecule catabolic process (GO:0016998) | 2.80072726 |
| 42 | innervation (GO:0060384) | 2.79527525 |
| 43 | response to hepatocyte growth factor (GO:0035728) | 2.79070310 |
| 44 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.79070310 |
| 45 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.78106762 |
| 46 | negative regulation of cell size (GO:0045792) | 2.76011778 |
| 47 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.75784462 |
| 48 | negative regulation of axon guidance (GO:1902668) | 2.75730417 |
| 49 | organelle transport along microtubule (GO:0072384) | 2.74845947 |
| 50 | dendritic spine morphogenesis (GO:0060997) | 2.73328195 |
| 51 | homocysteine metabolic process (GO:0050667) | 2.72340056 |
| 52 | neurotransmitter secretion (GO:0007269) | 2.71777050 |
| 53 | regulation of axon guidance (GO:1902667) | 2.71526523 |
| 54 | histone H3-K4 methylation (GO:0051568) | 2.71395155 |
| 55 | peptidyl-cysteine modification (GO:0018198) | 2.69986691 |
| 56 | protein targeting to lysosome (GO:0006622) | 2.68519437 |
| 57 | establishment of protein localization to vacuole (GO:0072666) | 2.68519437 |
| 58 | protein targeting to vacuole (GO:0006623) | 2.68519437 |
| 59 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.67482096 |
| 60 | diaphragm development (GO:0060539) | 2.62789811 |
| 61 | positive regulation of dendritic spine development (GO:0060999) | 2.62189501 |
| 62 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.62147081 |
| 63 | glial cell proliferation (GO:0014009) | 2.60240748 |
| 64 | long-term synaptic potentiation (GO:0060291) | 2.59760162 |
| 65 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.59209260 |
| 66 | endoplasmic reticulum organization (GO:0007029) | 2.58283094 |
| 67 | desmosome organization (GO:0002934) | 2.55856046 |
| 68 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.55604135 |
| 69 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.54880528 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.52466765 |
| 71 | response to parathyroid hormone (GO:0071107) | 2.52189565 |
| 72 | axon extension involved in axon guidance (GO:0048846) | 2.51876771 |
| 73 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.51876771 |
| 74 | positive regulation of macroautophagy (GO:0016239) | 2.50835985 |
| 75 | vocalization behavior (GO:0071625) | 2.49078388 |
| 76 | gamma-aminobutyric acid transport (GO:0015812) | 2.48813514 |
| 77 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.48364842 |
| 78 | phosphorelay signal transduction system (GO:0000160) | 2.47511150 |
| 79 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.47051347 |
| 80 | cellular response to vitamin D (GO:0071305) | 2.46122855 |
| 81 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.45126765 |
| 82 | negative regulation of vascular permeability (GO:0043116) | 2.44885405 |
| 83 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.44648599 |
| 84 | protein import into peroxisome matrix (GO:0016558) | 2.44604758 |
| 85 | negative regulation of microtubule polymerization (GO:0031115) | 2.44572286 |
| 86 | fear response (GO:0042596) | 2.44398279 |
| 87 | central nervous system neuron axonogenesis (GO:0021955) | 2.44390726 |
| 88 | response to nerve growth factor (GO:1990089) | 2.42768626 |
| 89 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.42768626 |
| 90 | regulation of synapse assembly (GO:0051963) | 2.41110322 |
| 91 | synaptic vesicle transport (GO:0048489) | 2.39539706 |
| 92 | establishment of synaptic vesicle localization (GO:0097480) | 2.39539706 |
| 93 | regulation of feeding behavior (GO:0060259) | 2.39025791 |
| 94 | neuron cell-cell adhesion (GO:0007158) | 2.39002716 |
| 95 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.38132147 |
| 96 | positive regulation of fibroblast migration (GO:0010763) | 2.37885023 |
| 97 | establishment of protein localization to Golgi (GO:0072600) | 2.35623999 |
| 98 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.35546131 |
| 99 | spermatid nucleus differentiation (GO:0007289) | 2.35408635 |
| 100 | vesicle docking involved in exocytosis (GO:0006904) | 2.35295832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.73853713 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.66459038 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.34760664 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.14779415 |
| 5 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.61019109 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58259921 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.57182886 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.37959963 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.32668357 |
| 10 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 2.32541641 |
| 11 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.29360086 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.26886411 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.24974385 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.21636438 |
| 15 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.17470416 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16927416 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.03675201 |
| 18 | TP53_16413492_ChIP-PET_HCT116_Human | 1.95639969 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94990159 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93378610 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86057505 |
| 22 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.85587640 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85148238 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.81886262 |
| 25 | STAT3_23295773_ChIP-Seq_U87_Human | 1.80519293 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.79955430 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71224720 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68678548 |
| 29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68042954 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66878454 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66607726 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.66599812 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.61503342 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.61107887 |
| 35 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.57844083 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57256613 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54300522 |
| 38 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53754690 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52217135 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.49197718 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48127644 |
| 42 | TCF4_23295773_ChIP-Seq_U87_Human | 1.46983060 |
| 43 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45363290 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44080851 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42944327 |
| 46 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.39034948 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35188642 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34887017 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33038699 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30250351 |
| 51 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.29414909 |
| 52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.28417736 |
| 53 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27078176 |
| 54 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.24428293 |
| 55 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.22604015 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22455737 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22103768 |
| 58 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.20666549 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19532786 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19200556 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19200556 |
| 62 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.19172519 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18867432 |
| 64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18309002 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17984883 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.14109119 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13451148 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12885815 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11906637 |
| 70 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10903885 |
| 71 | JUN_21703547_ChIP-Seq_K562_Human | 1.10612049 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09120149 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08811119 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08010751 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08010751 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07934912 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06901263 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06821443 |
| 79 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06433101 |
| 80 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05562135 |
| 81 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05492285 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04786683 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04568282 |
| 84 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04177591 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04095302 |
| 86 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03806139 |
| 87 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03424724 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01839908 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01741029 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01547461 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01388891 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01316490 |
| 93 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00645337 |
| 94 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.00244737 |
| 95 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.99847193 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99323237 |
| 97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97984177 |
| 98 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97358134 |
| 99 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.97055761 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96566193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005645_abnormal_hypothalamus_physiol | 4.29330689 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.68848779 |
| 3 | MP0003787_abnormal_imprinting | 3.21284384 |
| 4 | MP0003880_abnormal_central_pattern | 2.90274233 |
| 5 | MP0004270_analgesia | 2.88341304 |
| 6 | MP0003195_calcinosis | 2.86578520 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.70823460 |
| 8 | MP0002234_abnormal_pharynx_morphology | 2.48858085 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.39688555 |
| 10 | MP0000778_abnormal_nervous_system | 2.26872823 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.20324074 |
| 12 | MP0004043_abnormal_pH_regulation | 2.04867283 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.03661766 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.03192072 |
| 15 | MP0003123_paternal_imprinting | 1.99259968 |
| 16 | MP0001501_abnormal_sleep_pattern | 1.96697989 |
| 17 | MP0004811_abnormal_neuron_physiology | 1.90860887 |
| 18 | MP0009046_muscle_twitch | 1.90667398 |
| 19 | MP0000516_abnormal_urinary_system | 1.90184288 |
| 20 | MP0005367_renal/urinary_system_phenotyp | 1.90184288 |
| 21 | MP0005423_abnormal_somatic_nervous | 1.77834335 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 1.76696515 |
| 23 | MP0001188_hyperpigmentation | 1.75829535 |
| 24 | MP0002184_abnormal_innervation | 1.74906712 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 1.73055767 |
| 26 | MP0004233_abnormal_muscle_weight | 1.71587284 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.69998978 |
| 28 | MP0004858_abnormal_nervous_system | 1.68368109 |
| 29 | MP0002272_abnormal_nervous_system | 1.67382919 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.66565362 |
| 31 | MP0009745_abnormal_behavioral_response | 1.66249403 |
| 32 | MP0002064_seizures | 1.62229042 |
| 33 | MP0000631_abnormal_neuroendocrine_gland | 1.61914586 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.59847447 |
| 35 | MP0000955_abnormal_spinal_cord | 1.58611081 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.56231142 |
| 37 | MP0001661_extended_life_span | 1.53703031 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.53664948 |
| 39 | MP0003890_abnormal_embryonic-extraembry | 1.53362215 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.45053060 |
| 41 | MP0003045_fibrosis | 1.39140800 |
| 42 | MP0003122_maternal_imprinting | 1.38052766 |
| 43 | MP0008438_abnormal_cutaneous_collagen | 1.35732675 |
| 44 | MP0004147_increased_porphyrin_level | 1.35025932 |
| 45 | MP0000566_synostosis | 1.32741573 |
| 46 | MP0003121_genomic_imprinting | 1.31400791 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.31368128 |
| 48 | MP0004885_abnormal_endolymph | 1.30499246 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.30008698 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.29841517 |
| 51 | MP0002736_abnormal_nociception_after | 1.28584102 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.26986163 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.25115987 |
| 54 | MP0001486_abnormal_startle_reflex | 1.24144953 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.23155950 |
| 56 | MP0001984_abnormal_olfaction | 1.23044203 |
| 57 | MP0005451_abnormal_body_composition | 1.18515191 |
| 58 | MP0005409_darkened_coat_color | 1.18040113 |
| 59 | MP0001970_abnormal_pain_threshold | 1.17107605 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.13339104 |
| 61 | MP0005187_abnormal_penis_morphology | 1.11854324 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.08364254 |
| 63 | MP0003633_abnormal_nervous_system | 1.06403205 |
| 64 | MP0002152_abnormal_brain_morphology | 1.05874309 |
| 65 | MP0002751_abnormal_autonomic_nervous | 1.05070241 |
| 66 | MP0001270_distended_abdomen | 1.04477470 |
| 67 | MP0005275_abnormal_skin_tensile | 1.03756596 |
| 68 | MP0003879_abnormal_hair_cell | 1.01299209 |
| 69 | MP0002069_abnormal_eating/drinking_beha | 0.93221610 |
| 70 | MP0002295_abnormal_pulmonary_circulatio | 0.92901634 |
| 71 | MP0002752_abnormal_somatic_nervous | 0.92496841 |
| 72 | MP0003631_nervous_system_phenotype | 0.90801489 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.90341886 |
| 74 | MP0002557_abnormal_social/conspecific_i | 0.87774156 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.87335329 |
| 76 | MP0001919_abnormal_reproductive_system | 0.87078263 |
| 77 | MP0002066_abnormal_motor_capabilities/c | 0.86580361 |
| 78 | MP0003172_abnormal_lysosome_physiology | 0.85643705 |
| 79 | MP0003385_abnormal_body_wall | 0.83382389 |
| 80 | MP0003937_abnormal_limbs/digits/tail_de | 0.83054515 |
| 81 | MP0003861_abnormal_nervous_system | 0.81150372 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.80931521 |
| 83 | MP0000534_abnormal_ureter_morphology | 0.80833298 |
| 84 | MP0008569_lethality_at_weaning | 0.78343529 |
| 85 | MP0002733_abnormal_thermal_nociception | 0.77353416 |
| 86 | MP0003935_abnormal_craniofacial_develop | 0.77330039 |
| 87 | MP0003646_muscle_fatigue | 0.75505316 |
| 88 | MP0000647_abnormal_sebaceous_gland | 0.75223186 |
| 89 | MP0002009_preneoplasia | 0.74819384 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.71786472 |
| 91 | MP0002081_perinatal_lethality | 0.69615971 |
| 92 | MP0001286_abnormal_eye_development | 0.69325505 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.69086251 |
| 94 | MP0002168_other_aberrant_phenotype | 0.68694700 |
| 95 | MP0001915_intracranial_hemorrhage | 0.67894518 |
| 96 | MP0008995_early_reproductive_senescence | 0.67095607 |
| 97 | MP0002928_abnormal_bile_duct | 0.66340054 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.65898776 |
| 99 | MP0002229_neurodegeneration | 0.65241355 |
| 100 | MP0004130_abnormal_muscle_cell | 0.65031852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sparse lateral eyebrow (HP:0005338) | 3.56297533 |
| 2 | Action tremor (HP:0002345) | 3.36638646 |
| 3 | Fatigue (HP:0012378) | 3.35862555 |
| 4 | Focal seizures (HP:0007359) | 3.16813275 |
| 5 | Focal motor seizures (HP:0011153) | 3.14215728 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.12005425 |
| 7 | Abnormality of alanine metabolism (HP:0010916) | 2.91868236 |
| 8 | Hyperalaninemia (HP:0003348) | 2.91868236 |
| 9 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.91868236 |
| 10 | Febrile seizures (HP:0002373) | 2.90492370 |
| 11 | Cortical dysplasia (HP:0002539) | 2.85016558 |
| 12 | Atonic seizures (HP:0010819) | 2.83022792 |
| 13 | Urinary urgency (HP:0000012) | 2.81607407 |
| 14 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.77502992 |
| 15 | Neoplasm of the adrenal cortex (HP:0100641) | 2.72963059 |
| 16 | Hepatoblastoma (HP:0002884) | 2.61703773 |
| 17 | Heterochromia iridis (HP:0001100) | 2.58323989 |
| 18 | Drooling (HP:0002307) | 2.52752053 |
| 19 | Asymmetry of the thorax (HP:0001555) | 2.51473096 |
| 20 | Abnormality of the fingertips (HP:0001211) | 2.46453026 |
| 21 | Medulloblastoma (HP:0002885) | 2.41937281 |
| 22 | Papilledema (HP:0001085) | 2.39753055 |
| 23 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.37377238 |
| 24 | Constricted visual fields (HP:0001133) | 2.28136909 |
| 25 | Excessive salivation (HP:0003781) | 2.27197046 |
| 26 | Spastic gait (HP:0002064) | 2.24028140 |
| 27 | Increased density of long bones (HP:0006392) | 2.23921974 |
| 28 | Absent eyebrow (HP:0002223) | 2.18324368 |
| 29 | Autoamputation (HP:0001218) | 2.17550013 |
| 30 | Ureteral obstruction (HP:0006000) | 2.16981684 |
| 31 | Anal stenosis (HP:0002025) | 2.16964607 |
| 32 | Ectopic kidney (HP:0000086) | 2.16859720 |
| 33 | Ureteral stenosis (HP:0000071) | 2.15816532 |
| 34 | Intention tremor (HP:0002080) | 2.15694515 |
| 35 | Ankle clonus (HP:0011448) | 2.13933478 |
| 36 | Abnormality of the astrocytes (HP:0100707) | 2.12781033 |
| 37 | Astrocytoma (HP:0009592) | 2.12781033 |
| 38 | Generalized myoclonic seizures (HP:0002123) | 2.12671790 |
| 39 | Overgrowth (HP:0001548) | 2.06152555 |
| 40 | Truncal ataxia (HP:0002078) | 2.06000782 |
| 41 | Long palpebral fissure (HP:0000637) | 2.05577388 |
| 42 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.03532932 |
| 43 | Concave nail (HP:0001598) | 2.02282814 |
| 44 | Bladder neoplasm (HP:0009725) | 2.01334864 |
| 45 | Bladder carcinoma (HP:0002862) | 2.01334864 |
| 46 | Agitation (HP:0000713) | 1.99015846 |
| 47 | Termporal pattern (HP:0011008) | 1.97792540 |
| 48 | Insidious onset (HP:0003587) | 1.97792540 |
| 49 | Amblyopia (HP:0000646) | 1.97702063 |
| 50 | Hemiparesis (HP:0001269) | 1.96811355 |
| 51 | Complete atrioventricular canal defect (HP:0001674) | 1.96382903 |
| 52 | Glioma (HP:0009733) | 1.96256472 |
| 53 | Broad ribs (HP:0000885) | 1.95416062 |
| 54 | Mild short stature (HP:0003502) | 1.95184919 |
| 55 | Cubitus valgus (HP:0002967) | 1.94326931 |
| 56 | Dialeptic seizures (HP:0011146) | 1.93899473 |
| 57 | Generalized tonic-clonic seizures (HP:0002069) | 1.93861409 |
| 58 | Abnormality of the periventricular white matter (HP:0002518) | 1.93834892 |
| 59 | Abnormality of the lower motor neuron (HP:0002366) | 1.91041562 |
| 60 | Tubulointerstitial nephritis (HP:0001970) | 1.89221482 |
| 61 | Absent speech (HP:0001344) | 1.87249485 |
| 62 | Pheochromocytoma (HP:0002666) | 1.85844489 |
| 63 | Absence seizures (HP:0002121) | 1.84035188 |
| 64 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.82996021 |
| 65 | Wide intermamillary distance (HP:0006610) | 1.81898829 |
| 66 | Short 5th finger (HP:0009237) | 1.81657533 |
| 67 | Keratoconus (HP:0000563) | 1.80939581 |
| 68 | Increased corneal curvature (HP:0100692) | 1.80939581 |
| 69 | Status epilepticus (HP:0002133) | 1.79440222 |
| 70 | Lower limb hyperreflexia (HP:0002395) | 1.79181142 |
| 71 | Ectropion (HP:0000656) | 1.78356721 |
| 72 | Hypoplastic nipples (HP:0002557) | 1.78062672 |
| 73 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.77242294 |
| 74 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.75449134 |
| 75 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.75287959 |
| 76 | Anhidrosis (HP:0000970) | 1.74811651 |
| 77 | Epileptiform EEG discharges (HP:0011182) | 1.74456443 |
| 78 | Increased circulating renin level (HP:0000848) | 1.74353334 |
| 79 | Depression (HP:0000716) | 1.73673097 |
| 80 | Visceral angiomatosis (HP:0100761) | 1.73419441 |
| 81 | Neoplasm of the heart (HP:0100544) | 1.72553243 |
| 82 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71652312 |
| 83 | Ependymoma (HP:0002888) | 1.71080061 |
| 84 | Hammertoe (HP:0001765) | 1.67925939 |
| 85 | Progressive cerebellar ataxia (HP:0002073) | 1.66353512 |
| 86 | Lower limb muscle weakness (HP:0007340) | 1.65863891 |
| 87 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.64741332 |
| 88 | Hypsarrhythmia (HP:0002521) | 1.63214721 |
| 89 | Orthostatic hypotension (HP:0001278) | 1.62973238 |
| 90 | Myokymia (HP:0002411) | 1.62781345 |
| 91 | Clonus (HP:0002169) | 1.62559588 |
| 92 | Depressed nasal tip (HP:0000437) | 1.62365944 |
| 93 | Delayed CNS myelination (HP:0002188) | 1.60940473 |
| 94 | Atrioventricular canal defect (HP:0006695) | 1.60681018 |
| 95 | Short chin (HP:0000331) | 1.60302066 |
| 96 | Unsteady gait (HP:0002317) | 1.60134345 |
| 97 | Failure to thrive in infancy (HP:0001531) | 1.59436626 |
| 98 | Delusions (HP:0000746) | 1.58913732 |
| 99 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.58345937 |
| 100 | Hemangiomatosis (HP:0007461) | 1.57451466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.43643736 |
| 2 | MARK1 | 3.21283802 |
| 3 | NTRK2 | 3.04114818 |
| 4 | CCNB1 | 2.84946900 |
| 5 | MAP3K4 | 2.83809323 |
| 6 | EPHA3 | 2.65911586 |
| 7 | MAP2K7 | 2.55874832 |
| 8 | STK24 | 2.48631362 |
| 9 | BCKDK | 2.13330664 |
| 10 | EPHA4 | 2.08253696 |
| 11 | TESK2 | 1.95798397 |
| 12 | NTRK3 | 1.94467289 |
| 13 | PLK2 | 1.92539674 |
| 14 | JAK3 | 1.71392010 |
| 15 | FRK | 1.64957222 |
| 16 | CAMK1G | 1.64564003 |
| 17 | TAOK3 | 1.60395438 |
| 18 | MAPK13 | 1.55957515 |
| 19 | WNK1 | 1.55866795 |
| 20 | SRPK1 | 1.54588852 |
| 21 | SGK2 | 1.50356875 |
| 22 | ERBB3 | 1.48084440 |
| 23 | MINK1 | 1.46592282 |
| 24 | SGK494 | 1.46585997 |
| 25 | SGK223 | 1.46585997 |
| 26 | DAPK2 | 1.40951633 |
| 27 | CAMKK2 | 1.39756011 |
| 28 | MAP3K2 | 1.39737205 |
| 29 | CAMK1D | 1.38489558 |
| 30 | MAP3K3 | 1.37035564 |
| 31 | ZAK | 1.31225229 |
| 32 | PAK6 | 1.30880702 |
| 33 | NTRK1 | 1.29467018 |
| 34 | SGK3 | 1.28836988 |
| 35 | WNK4 | 1.28460739 |
| 36 | CSNK1A1L | 1.12354247 |
| 37 | PAK3 | 1.11681607 |
| 38 | AKT3 | 1.11651840 |
| 39 | CAMK1 | 1.10795602 |
| 40 | CAMK4 | 1.10176730 |
| 41 | BCR | 1.09313777 |
| 42 | TRIM28 | 1.09288023 |
| 43 | PINK1 | 1.08860869 |
| 44 | CDK9 | 1.06267612 |
| 45 | CLK1 | 1.02885293 |
| 46 | MAP4K2 | 1.02868807 |
| 47 | FLT3 | 1.01143839 |
| 48 | EIF2AK3 | 0.97499674 |
| 49 | DYRK3 | 0.97488218 |
| 50 | UHMK1 | 0.96447448 |
| 51 | CSNK1G3 | 0.93519893 |
| 52 | SCYL2 | 0.92087368 |
| 53 | DYRK2 | 0.91589039 |
| 54 | BRD4 | 0.81725947 |
| 55 | CSNK1G2 | 0.80807996 |
| 56 | STK39 | 0.78162583 |
| 57 | FGR | 0.77878403 |
| 58 | SIK2 | 0.77669331 |
| 59 | MAP3K6 | 0.77641806 |
| 60 | PRKCG | 0.77212771 |
| 61 | CDK5 | 0.76737566 |
| 62 | PRKD3 | 0.76655098 |
| 63 | DAPK1 | 0.71086498 |
| 64 | CAMKK1 | 0.71065470 |
| 65 | MAP2K4 | 0.70440214 |
| 66 | SGK1 | 0.67834799 |
| 67 | EEF2K | 0.67547800 |
| 68 | PDGFRA | 0.59123101 |
| 69 | CSNK1G1 | 0.57937263 |
| 70 | RPS6KA2 | 0.53042385 |
| 71 | EIF2AK1 | 0.52188439 |
| 72 | PRKCE | 0.50105538 |
| 73 | MTOR | 0.49832043 |
| 74 | JAK1 | 0.49791297 |
| 75 | CAMK2B | 0.49324833 |
| 76 | RPS6KA4 | 0.49019131 |
| 77 | DYRK1B | 0.43970216 |
| 78 | ILK | 0.42330215 |
| 79 | PRKAA1 | 0.41996434 |
| 80 | CDK6 | 0.41881086 |
| 81 | MAP3K5 | 0.41829863 |
| 82 | FER | 0.41439432 |
| 83 | YES1 | 0.39128852 |
| 84 | PRKCQ | 0.38335290 |
| 85 | PKN2 | 0.38099082 |
| 86 | NEK1 | 0.37347467 |
| 87 | CDK19 | 0.35488763 |
| 88 | MAPK10 | 0.35483923 |
| 89 | CAMK2A | 0.34209212 |
| 90 | CHEK2 | 0.33374094 |
| 91 | PHKG2 | 0.32758463 |
| 92 | PHKG1 | 0.32758463 |
| 93 | PNCK | 0.32254171 |
| 94 | NEK6 | 0.32084233 |
| 95 | PRKCH | 0.31961741 |
| 96 | CDK14 | 0.31727405 |
| 97 | RPS6KL1 | 0.31382966 |
| 98 | RPS6KC1 | 0.31382966 |
| 99 | WNK3 | 0.31220714 |
| 100 | RAF1 | 0.29856394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.54636369 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.91735050 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.54677578 |
| 4 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.54668972 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.47755048 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.47497045 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.45658779 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16029320 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79657680 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73619387 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.70214474 |
| 12 | Long-term depression_Homo sapiens_hsa04730 | 1.64808519 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64249041 |
| 14 | Axon guidance_Homo sapiens_hsa04360 | 1.54287514 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.53436867 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46118997 |
| 17 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.40190770 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.39198383 |
| 19 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.36299165 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.35445439 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24807345 |
| 22 | Alcoholism_Homo sapiens_hsa05034 | 1.23210091 |
| 23 | Lysine degradation_Homo sapiens_hsa00310 | 1.22897504 |
| 24 | Glioma_Homo sapiens_hsa05214 | 1.11850076 |
| 25 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04957681 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03401238 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.02680231 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02027451 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 0.99476066 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 0.99251255 |
| 31 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.99171069 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.98015032 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97695829 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96543700 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94855335 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92527677 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 0.91787689 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91362653 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90756532 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88117130 |
| 41 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87921927 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87176623 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86972909 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85585637 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84500298 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 0.82593556 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82323841 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82277007 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81773355 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 0.81377241 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80240553 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78969939 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78741200 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.78303619 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78046126 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76717627 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76298423 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73058129 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72532866 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71689535 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71609943 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.70580752 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68490928 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68318696 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68217187 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67866206 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67157463 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.67069671 |
| 69 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66038021 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65579531 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64440609 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64168697 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.61393482 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60429115 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59900120 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.57481594 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56926423 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56862397 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56515217 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56395751 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54756554 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54240637 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53932482 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53308078 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51175550 |
| 86 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51058709 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.50610883 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50261894 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50037787 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49900280 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46991952 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46233541 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45901742 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43032781 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42612942 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42509131 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41215405 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40196997 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38966539 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37321653 |

